08:04 AM EST, 11/03/2025 (MT Newswires) -- UniQure ( QURE ) shares were 65% lower pre-bell Monday after the company said it believes that the US Food and Drug Administration no longer considers its Huntington's disease therapy data adequate to support a biologics license application.

ClearPoint Neuro ( CLPT ) stock was down 23% following a 1.9% loss in the previous session.

Alvotech ( ALVO ) shares were 23% lower, adding to Friday's 2.4% decrease.

NewcelX (NCEL) stock was down 18%, paring Friday's rally.